Philadelphia Cataracts Surgeon – Dr. James S. Lewis
Serving Delaware Valley, Montgomery County, Warminster, Conshohocken, Phoenixville and King of Prussia
The word “Cataract” can evoke undue concern and trepidation. Instead, cataract surgery should be viewed as an opportunity to regain lost vision and, in many cases, improve it. As a leading Philadelphia cataract surgeon, Dr. Lewis is committed to exploring the risks, benefits and alternatives with each cataract patient when providing the most common and most successful surgical intervention of the modern era.
Hassle Free Cataract Surgery
Despite excellent insurance coverage, post-operative eye drops still cost the patient between $100 and $300 out of pocket.
Until now, these drops were required two to four times a day for several weeks. Based on the results of the European Endophthalmitis Study and the work of James Gills, MD and Jeff Liegner, MD, Dr. James Lewis now applies these medications in a long acting formulation at the time of surgery.
Dr. Lewis patients are no longer required to purchase or use post-operative eye drops*. This eliminates costly co-pays and a visit to the pharmacy.
In addition to cost, patients do not have to worry about timely and sterile instillation of these medications.
For more information, call 215 886-9090 and ask about Hassle Free cataract surgery or chat with us online.
* In less than 10% of patients a brief post-operative course of anti-inflammatories may be required.
Refractive Cataract Surgery
For those who want to limit their dependence on glasses and contacts following cataract surgery.
Implant and endpoint selection in consultation with your doctor may provide a superior experience and a preferred visual result.
nanoFLEX DCB for Near and Intermediate Vision
nanoFLEX is a premium intraocular lens implant (IOL) manufactured by STAAR Surgical, a small high-tech company known for creating the field of small incision, sutureless cataract surgery. Their introduction of the first foldable intraocular lens in the early 1990’s was just one of their groundbreaking contributions to ophthalmology. STAAR developed the STAAR Toric for the correction of astigmatism almost a decade before Alcon, the “800 lb. gorilla” in the field of ophthalmology. STAAR also developed
the Visian ICL, an intraocular lens to compete with LASIK.
Meet Dr. James S. Lewis
Dr. James S. Lewis is proud to have helped numerous Delaware Valley, Jenkintown, Abington, Northeast Philadelphia, Fort Washington, Elkins Park, Phoenixville, Conshohocken, Warminster, Montgomery County and Bucks County cataracts patients improve their vision. A member of the Wills Eye Surgical Network since 1996, Dr. James Lewis is a graduate of Princeton University and Thomas Jefferson Medical College, where he won awards in Ophthalmology and Research.
He served as chief resident during his third year at Duke University Eye Center, where he was offered a faculty position. Instead, he travelled to South Australia for subspecialty training in Corneal and Refractive Surgery. He returned in 1990 and became Director of Cornea and Anterior Segment Surgery at Hahnemann University in Philadelphia. Dr. Lewis also served as Corneal Consultant to the Pennsylvania College of Optometry. Click on the link below to watch Dr. Lewis – a top Philadelphia cataracts surgeon – speak about his practice.
Dr. Lewis designated as a member of the prestigious
PS250 by Ocular Surgery News.
So, we gathered together the names of surgeons we knew were educating their colleagues about the topic at Hawaiian Eye, Kiawah Eye, OSN New York and AAO; conducting research to optimize patient clinical outcomes; digging into the diagnostic technology to assist in selecting the best patient, and the best lens for that patient; looking into the unique business aspects of premium IOL surgery; and, of course, the early adopters who saw great promise in the IOL technology.
3D Cataract Animations
Watch Cataract Surgery
Cataract Surgery Results
95% of cataract/aquaflow patients get off of one glaucoma eye drop**
50% of cataract/aquaflow patients do not require any glaucoma eye drops after surgery*** this was the result of a retrospective study of 2500 consecutive cataract surgeries performed at the Pennsylvania College of Optometry between 2004 and 2007 with a visual potential (either pinhole or interferometry).
** retrospective study of 500 consecutive cataract/aquafow surgeries performed at the Pennsylvania College of Optometry between 2003 and 2009 on at least one anti-glaucoma medication.